Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Soleno Therapeutics (SLNO) Other Operating Expenses (2016 - 2017)

Historic Other Operating Expenses for Soleno Therapeutics (SLNO) over the last 3 years, with Q4 2017 value amounting to $1000.0.

  • Soleno Therapeutics' Other Operating Expenses rose 29840.64% to $1000.0 in Q4 2017 from the same period last year, while for Sep 2018 it was $1000.0, marking a year-over-year decrease of 6924.02%. This contributed to the annual value of $3.2 million for FY2024, which is 1945.47% up from last year.
  • According to the latest figures from Q4 2017, Soleno Therapeutics' Other Operating Expenses is $1000.0, which was up 29840.64% from $5000.0 recorded in Q3 2017.
  • Soleno Therapeutics' 5-year Other Operating Expenses high stood at $156359.0 for Q4 2014, and its period low was -$94000.0 during Q1 2016.
  • Over the past 3 years, Soleno Therapeutics' median Other Operating Expenses value was $3000.0 (recorded in 2017), while the average stood at $20326.2.
  • Within the past 5 years, the most significant YoY rise in Soleno Therapeutics' Other Operating Expenses was 29840.64% (2017), while the steepest drop was 9787.23% (2017).
  • Quarter analysis of 3 years shows Soleno Therapeutics' Other Operating Expenses stood at $156359.0 in 2014, then plummeted by 99.84% to $251.0 in 2016, then surged by 298.41% to $1000.0 in 2017.
  • Its Other Operating Expenses was $1000.0 in Q4 2017, compared to $5000.0 in Q3 2017 and -$2000.0 in Q1 2017.